Rofida Osama Abdel Gawad Nofal, MD
Pediatrics · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Nofal’s office at (650) 497-8000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A147035 · Current
Licensed to practise in California · since 2017 · expires 2028-06-30 · Zagazig Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Pediatrics - Pediatrics
Medicaid work
$63,149 in 2024
Medicaid paid $63,149 for 791 billed services this clinician did in 2024, up to 86 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 297 | $62,183 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 41 | $577 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 40 | $310 |
| Short return visit (20+ min) | 366 | $79 |
| Bilateral quantitative screening test of visual acuity | 13 | $0 |
| Screening performed and negative | 34 | $0 |
| 2024 | 791 | 6 | 86 | $63,149 |
| 2023 | 3,259 | 11 | 101 | $223,648 |
| 2022 | 1,022 | 10 | 104 | $62,454 |
| 2019 | 13 | 1 | 13 | $1,744 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,080 | $219,049 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 220 | $1,800 |
| Pure tone audiometry (threshold); air only | 164 | $1,490 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 112 | $645 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 19 | $230 |
| Screening performed and negative | 186 | $203 |
| Short return visit (20+ min) | 1,215 | $159 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 24 | $60 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 101 | $13 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 56 | $0 |
| Bilateral quantitative screening test of visual acuity | 82 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 298 | $59,662 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 63 | $1,248 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 120 | $585 |
| Pure tone audiometry (threshold); air only | 73 | $436 |
| Screening performed and negative | 81 | $406 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 31 | $90 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 28 | $27 |
| Bilateral quantitative screening test of visual acuity | 33 | $0 |
| Short return visit | 29 | $0 |
| Short return visit (20+ min) | 266 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 13 | $1,744 |
Professional record
- NPI
- 1578979340
- Licence
- CA A147035California A147035: Current · expires 2028-06-30
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2014-07-01
- NPI last updated
- 2022-10-25
- NPI record certified
- 2022-10-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 747 52nd St, Oakland, CA, 94609